Literature DB >> 1097926

Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease.

K W Pyke, H Dosch, M M Ipp, E W Gelfand.   

Abstract

An in vitro system has been developed to elucidate the nature of the cellular defect in primary immunodeficiency diseases. Incubation, on human thymic epithelial monolayer cultures, of peripheral blood lymphocytes and bone-marrow cells from a child with documented severe combined immunodeficiency disease resulted in the appearance of a population of cells that formed rosettes with sheep erythrocytes. The same cell preparation permitted the synthesis of antigen-specific, complement-dependent antibodies after in vitro education, as demonstrated in a plaque assay system. In addition, thymic tissue from the same child gave morphologic and functional evidence of maturation when cultured in vitro. The experimental results suggest that in this case, lymphoid precursor cells were present in the bone marrow but failed to differentiate to functional maturity due to a defect in maturation of thymic tissue.

Entities:  

Mesh:

Year:  1975        PMID: 1097926     DOI: 10.1056/NEJM197508282930904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

1.  Cultured human thymus epithelial monolayer cells induce CD4 expression on mononuclear cells of AIDS patients in vitro.

Authors:  H J Schuurman; R W Hendriks; J M Lange; J A van der Linden; F H Gmelig Meyling; S A Danner; L Kater
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

Review 2.  Ontogeny of the human thymus during fetal development.

Authors:  D F Lobach; B F Haynes
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

3.  Alterations of the thymus and other lymphoid tissue in young horses with combined immunodeficiency.

Authors:  T C McGuire; K L Banks; W C Davis
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

4.  Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Authors:  R Pahwa; T Chatila; S Pahwa; C Paradise; N K Day; R Geha; S A Schwartz; H Slade; N Oyaizu; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.

Authors:  L K Jung; S M Fu; T Hara; N Kapoor; R A Good
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells.

Authors:  R N Pahwa; S G Pahwa; R A Good
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

7.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

8.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.

Authors:  K C Rich; C M Richman; E Mejias; P Daddona
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Heterogeneity of stem cells in severe combined immunodeficiency.

Authors:  G S Incefy; E Grimes; W A Kagan; G Goldstein; E Smithwick; R O'Reilly; R A Good
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.